Arrowstreet Capital’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Arrowstreet Capital’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,850	Closed	-$111K	–	2579
2020 Q2	$111K	Buy	+1,850	New	+$169K	﹤0.01%	2218
2020 Q1	–	Sell	-15,788	Closed	-$2.17M	–	2184
2019 Q4	$2.17M	Sell	15,788 -1,528	-9%	-$186K	0.01%	1117
2019 Q3	$2.06M	Buy	17,316 +13,291	+330%	+$1.85M	﹤0.01%	978
2019 Q2	$563K	Buy	+4,025	New	+$707K	﹤0.01%	1161

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Arrowstreet Capital's ORTX Position: Q3 2020 in Review

Arrowstreet Capital sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2020, closing a stake of 1,850 shares — an estimated $111K sold.

Arrowstreet Capital first reported a position in ORTX in Q2 2019 and held it in 4 quarters. The position peaked at $2.17M in Q4 2019. 72 funds tracked by Wall St. Rank hold ORTX as of Q3 2020.

Arrowstreet Capital reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Arrowstreet Capital sold 1,850 Orchard Therapeutics plc American Depositary Shares shares in Q3 2020, an estimated $111K.
Arrowstreet Capital first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 4 quarters.
Arrowstreet Capital's Orchard Therapeutics plc American Depositary Shares position peaked at $2.17M in Q4 2019.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2020.

Based on Arrowstreet Capital's 13F filing for Q3 2020, filed 12 Nov 2020.